Turcot syndrome (disorder)
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Metachronous Wilms Tumor, Glioblastoma, and T-cell Leukemia in an Child With Constitutional Mismatch Repair Deficiency syndrome due to Novel Mutation in MSH6 (c.2590G>T).
|
31815888 |
2019 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
Cumulative colorectal cancer incidence was estimated in a cohort of PMS2- and MSH6-associated families, ascertained by the CMMRD phenotype of the index, by using mutation probabilities based on kinship coefficients as analytical weights in a proportional hazard regression on the cause-specific hazards.
|
31204389 |
2019 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
Six (7%) tumors were p53 abnormal, 82 (91%) were p53 normal, and 2 (2%) tumors had MMR deficiency (1 MSH6 loss and 1 MSH2/6 loss; both were p53 normal).
|
31335355 |
2019 |
Turcot syndrome (disorder)
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Thirteen patients (15.7%) had tumor MMR deficiency due to a presumed germline mutation (9 MSH6, 3 MSH2, and 1 MLH1).
|
27327152 |
2016 |
Turcot syndrome (disorder)
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
MMR deficiency was most commonly due to alterations in MSH2 (53%) or MSH6 (23%).
|
27432916 |
2016 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database.
|
24362816 |
2014 |
Turcot syndrome (disorder)
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Tumor MMR-deficiency was observed for 22 cases [69 %; 95 % confidence interval (CI) 50-83 %], with the highest prevalence of MMR-deficiency in tumors from MSH2 mutation carriers (19/23, 83 %) compared with MLH1 and MSH6 carriers combined (3/9, 33 %; p = 0.01).
|
25117503 |
2014 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
Mutations in MSH6 have also been found but these do not always cause a clear cancer predisposition phenotype and MSH6-defective tumors often do not show the standard characteristics of MMR deficiency, such as microsatellite instability.
|
24040339 |
2013 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
|
23788249 |
2013 |
Turcot syndrome (disorder)
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Simple detection of germline microsatellite instability for diagnosis of constitutional mismatch repair cancer syndrome.
|
23483711 |
2013 |
Turcot syndrome (disorder)
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
We present a deficient MMR system, in a PJS patient, which demonstrated low mRNA levels of hMSH6 and hPMS2 and an increasing MMR deficiency from the non-dysplastic lesion to hamartomatous polyp of PJS with a high risk of cancer.
|
23677888 |
2013 |
Turcot syndrome (disorder)
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Whole-exome capture and massively parallel sequencing combined with homozygosity mapping identified a homozygous novel mutation in the MSH6 gene that leads to constitutional mismatch repair deficiency syndrome and increased cancer risk.
|
22493294 |
2012 |
Turcot syndrome (disorder)
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
MSH6 was absent in one pediatric MSI-High tumor, consistent with an inherited mismatch repair deficiency associated with germline MSH6 mutation.
|
21637783 |
2011 |
Turcot syndrome (disorder)
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Constitutional mismatch repair-deficiency syndrome.
|
20442441 |
2010 |
Turcot syndrome (disorder)
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We report on a case with constitutional mismatch repair deficiency caused by a novel MSH6 mutation leading to a T-cell lymphoma and colonic adenocarcinoma at six and 13 years of age, respectively.
|
20015892 |
2010 |
Turcot syndrome (disorder)
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Loss of MSH6 expression is the predominant cause of MMR deficiency in early-onset CRC.
|
20924129 |
2010 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
BEFREE |
We propose that staining for PMS2 and MSH6 alone will be sufficient to detect all cases of mismatch repair deficiency and should replace routine screening with all four antibodies.
|
20632815 |
2010 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Compound heterozygosity for two MSH6 mutations in a patient with early onset colorectal cancer, vitiligo and systemic lupus erythematosus.
|
18409202 |
2008 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference.
|
18030674 |
2008 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Zebrafish with mutations in mismatch repair genes develop neurofibromas and other tumors.
|
18593904 |
2008 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation.
|
17557300 |
2007 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations.
|
17259933 |
2007 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Our findings support a role for MSH6 in Turcot syndrome and are consistent with an autosomal recessive mode of inheritance.
|
16000562 |
2005 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Neurofibromatosis von Recklinghausen type I phenotype and early onset of cancers in siblings compound heterozygous for mutations in MSH6.
|
16283678 |
2005 |
Turcot syndrome (disorder)
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Our findings support a role for MSH6 in Turcot syndrome and are consistent with an autosomal recessive mode of inheritance.
|
16000562 |
2005 |